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Fluorescent polymeric nanovehicles for neural
stem cell modulation†
S. A. Papadimitriou,a M. P. Robin,b D. Ceric,c R. K. O’Reilly,b S. Marinoc and
M. Resmini*a
Nanomaterials are emerging as strong candidates for applications in drug delivery and oﬀer an alternative
platform to modulate the diﬀerentiation and activity of neural stem cells. Herein we report the synthesis
and characterization of two diﬀerent classes of polymeric nanoparticles: N-isopropylacrylamide-based
thermoresponsive nanogels RM1 and P(TEGA)-b-P(D,LLA)2 nano-micelles RM2. We covalently linked the
nanoparticles with ﬂuorescent tags and demonstrate their ability to be internalized and tracked in neural
stem cells from the postnatal subventricular zone, without aﬀecting their proliferation, multipotency and
diﬀerentiation characteristics up to 150 μg ml−1. The diﬀerence in chemical structure of RM1 and RM2
does not appear to impact toxicity however it inﬂuences the loading capacity. Nanogels RM1 loaded with
retinoic acid improve solubility of the drug which is released at 37 °C, resulting in an increase in the
number of neurons, comparable to what can be obtained with a solution of the free drug solubilised with
a small percentage of DMSO.
Introduction
Ageing, neurodegenerative diseases and neurovascular
disorders are increasingly common conditions associated
with major irreversible loss of neurons and glial cells, resulting
in high mortality and high health care costs.1 Traditionally,
neurodegenerative diseases have been clinically approached
by alleviation of major symptoms. A number of promising
strategies, designed to achieve brain protection, repair and
recovery, have been investigated, such as delivery of neuro-
protective compounds to prevent cellular degeneration,2 use of
tissue engineering, cell replacement and cell transplantation.3
However sustained bioavailability and poor cell survival and
integration in the host have considerably limited the
applications.
A more recent and attractive approach has focused on tar-
geting endogenous neural stem cells (NSC), an important
reservoir of self-renewing and multipotent cells that can drive
regeneration and repair, hence conferring a certain degree of
plasticity to the adult brain.2 The subventricular zone (SVZ) of
the lateral ventricle and the subgranular zone of the dentate
gyrus are the best characterized neurogenic areas in the adult
mammalian brain.3,4 Their identification and characterization
has opened novel opportunities to design strategies aiming at
replenishing depleted neurons by means of increasing the
pool of endogenous progenitors, and controlling the diﬀeren-
tiation towards a specific lineage.5
In recent years developments in nanotechnology, in particu-
lar with novel functional nanomaterials characterized by high
surface to volume ratio, very small size and low polydispersity,
have led to interesting results in the field of drug delivery,
especially targeting the brain.6 Among the diﬀerent materials
investigated poly(alky cyanoacrylates), such as poly(butyl cyano-
acrylate) (PBCA)7 or poly(isohexyl cyanoacrylate) (PIHCA),8
poly(lactic acid) (PLA),9 human serum albumin (HSA),10 chito-
san11 and magnetic nanoparticles12 have shown promising
results.13 These materials frequently function as excipients but
are commonly described as drug delivery systems. The cargos
include a variety of small molecule drugs as well as growth
factors, proteins and macromolecules, well known for their
pharmacological activities in the brain, like nerve growth
factor (NGF),7 doxorubicin,8 siRNA,14 curcumin and retinoic
acid.15 More recently the potential application of polyethylenei-
mine (PEI) based nanoparticles for neural drug delivery has
also been reported using retinoic acid, a drug known to
promote neuronal diﬀerentiation but limited by low solubility
in aqueous solutions and rapid cellular metabolism.16
The cationic nature of PEI allows disruption of the endo-
somes and phagosomes created during the internalization of
the nanoparticles from the cells, via the ‘proton sponge’ eﬀect,
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c6nr06440j
aSchool of Biological and Chemical Science, Queen Mary University of London,
London E1 4NS, UK. E-mail: m.resmini@qmul.ac.uk
bDepartment of Chemistry, University of Warwick, Coventry CV4 7AL, UK
cBlizard Institute, Barts & The London School of Medicine and Dentistry,
Queen Mary University of London, E1 2AT, UK
17340 | Nanoscale, 2016, 8, 17340–17349 This journal is © The Royal Society of Chemistry 2016
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
7 
Se
pt
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
on
 2
7/
02
/2
01
7 
14
:2
8:
00
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
View Journal  | View Issue
allowing the release of the encapsulated drug in the
cytosol.17,18 The ability of PEI to mediate endocytosis of
nanoparticles was demonstrated with magnetic polymeric
nanospheres,19 using a fluorescent tag encapsulated in the
polymer matrix. However the concerns and data available
regarding the cytotoxicity of PEI based delivery agents, as a
result of their polycationic nature represent a limitation to
such systems.20,21
The literature available on this topic suggests that the mor-
phology and physical chemical characteristics of the nano-
systems have considerable impact on their suitability to be
used for drug delivery in vivo. The flexibility of the matrices
and their stability in aqueous environment can influence their
membrane permeability and ultimately the bioavailability of
the drug.
The aim of this work was to develop fluorescent polymeric
nanoparticles that could act as delivery vehicle for neural stem
cells, allowing tracking of cell internalization by fluorescence
microscopy, and contribute to the understanding of how nano-
particle morphology can impact suitability for drug delivery
applications. We synthesized and characterized two diﬀerent
types of polymeric nanoparticles, a thermoresponsive
N-isopropylacrylamide (NIPAM) based crosslinked nanogel and
a self-assembled block copolymer micelle system, and we
covalently tagged the two nanosystems with fluorescent
labels.22,23 We demonstrate that both sets of nanoparticles are
eﬃciently internalized in murine neural stem cells, show no
evidence of toxicity and do not impact on proliferation, self-
renewal and diﬀerentiation, in concentrations up to 150 μg ml−1.
Successful loading of retinoic acid24,25 was achieved,
although the diﬀerent rigidity of the polymeric systems has a
significant eﬀect on the loading capacity of the two nano-
particles. NIPAM based nanogels were selected for in vitro
experiments on SVZ CD 133+ murine neural stem cells, based
on their ability to encapsulate a higher amount of pharmaceu-
tically active ingredient. Their pharmacological activity as drug
delivery systems was evaluated in comparison to the free drug
in solution.
Results and discussion
Fluorescent nanoparticles
The ability to visualize nanoparticles during cellular uptake is
a key priority for the development of novel delivery systems,
required to validate toxicity data and confirm that the matrices
are internalised. Although fluorescent labelling is one of the
most common approaches for tracking nanoparticles inter-
nalization in cells, other techniques like AFM have been used
lately for the same purpose.26 Fluorescent moieties are com-
monly encapsulated into a polymer matrix and used for such
applications, however the stability in vitro of these system is a
cause for concern, with the tags often becoming separated
from the matrix. We chose instead to covalently link the fluoro-
phore to the backbone of the polymer structure to avoid such
issues.
Given the diﬀerent type of polymeric systems chosen, two
fluorophores were identified. For the polymeric NIPAM nano-
gels, a naphthalimide-based fluorescent probe was selected, as
its versatile structure allows easy chemical modification
depending on the required application. The polymerizable
fluorescent probe N-2-(6-(4-methylpiperazin-1-yl)-1,3-dioxo-
1H-benzo[de]isoquinolin-2(3H)-yl-ethyl)acrylamide (FIM)
previously reported by our group23 was included as co-
monomer in the nanogel preparation.
In the case of the block copolymer micelles, it is highly
desirable to know the precise location of the fluorescent probe
within the core–corona structure. This knowledge was achieved
through the use of block-dye-block polymer containing the
highly emissive dithiomaleimide (DTM) fluorophore, pre-
viously developed in our group, which allows precise dye
incorporation at the core–corona interface of the resultant
micelles.27 This strategy has been shown to inhibit self-
quenching leading to concentration-independent emission,
with these particles previously demonstrated as in vitro con-
trast agents.28 In both cases the fluorescent molecules were co-
valently attached to the polymer backbone, thus avoiding
issues of leaking from the polymer-matrix, and generating mis-
leading results, while the similar spectral properties of
naphthalimide and DTM enabled identical imaging conditions
for both systems.
One of the two systems used here is based on NIPAM nano-
gels. The main advantages of NIPAM-based nanoparticles are
high solubility and stability, as well as ability to change the
conformation, in response to variations in temperature, which
allows the release of the entrapped drug. These features with
their structural characteristics29 make them strong candidates
for drug delivery.
Fluorescent thermoresponsive NIPAM (RM1) based nano-
gels were obtained by high dilution radical polymerization, a
method that allows the preparation of nanoparticles with
small size (10 to 30 nm) and low polydispersity,30 by varying
the concentration of monomers and crosslinker. The best
nanogel preparation was obtained by reacting 75% NIPAM,
20% methylenebisacrylamide (MBA) as crosslinker, and 5% of
fluorescent probe in DMSO with a total monomer concen-
tration (Cm) of 1%, initiated by 1% AIBN (Scheme 1). The pres-
ence of the same polymerizable unit on all reagents ensures
similar reactivity rates and incorporation ratio, while the con-
centration of fluorescent monomer was kept low to avoid sig-
nificant increase in hydrophobicity and size of the nano-
particles. The RM1 nanogels were obtained with >60% yield,
were shown to have good solubility in water up to 2 mg ml−1
and DLS analysis of 1 mg ml−1 solution in water showed par-
ticle size comprised between 10–20 nm (Table 1, Fig. S1 and
Table S1†), a range also confirmed by TEM, (Fig. 1A). Zeta
potential was measured as −21 mV, showing that the nanogels
had a slightly negative surface charge (Fig. S3†). Comparison
with NIPAM nanogel particles, made in identical experimental
conditions and with same percentage of crosslinker but
without fluorescent co-monomer, shows similar characteristics
in terms of size (Fig. S2†) and solubility, confirming the
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hypothesis that the introduction of the fluorescent tag in such
small quantity does not significantly impact the polymer’s
morphological characteristics.
DTM-labelled block copolymer micelles (RM2) were pre-
pared according to our previously reported strategy.27 The
highly emissive DTM fluorophore was incorporated into a dual
functional initiator, with subsequent ring-opening polymeriz-
ation of D,L-lactide, followed by reversible addition–fragmenta-
tion chain transfer (RAFT) polymerization of triethyleneglycol
acrylate (TEGA) producing an amphiphilic block copolymer
(Scheme 1), with Mn,NMR = 28.4 kg mol
−1, Mn,SEC = 20.1
kg mol−1, ĐSEC = 1.22. This use of orthogonal polymerization
techniques results in the location of the DTM fluorophore
between hydrophobic and hydrophilic blocks, so that sub-
sequent self-assembly by direct dissolution in water, produces
block copolymer micelles with the DTM fluorophore at the
core–corona interface. DLS analysis indicated micelles with a
diameter of approximately 50 nm (Fig. S4† and Tables 1, S2†).
Zeta potential was measured as −27 mV, showing that the
micelles also had a slightly negative surface charge (Fig. S3†).
The morphology of the spherical micelles31 was confirmed by
TEM (using a graphene oxide substrate), where the size of the
particles was consistent with observation of the micelle core
(Fig. 1B).
Scheme 1 Preparation of RM1 nanogels (top) and RM2 micelles (bottom), and subsequent loading with retinoic acid; (i) high dilution radical
polymerization, (AIBN, DMSO, 70 °C); (ii) ring-opening polymerization of D,L-lactide (1-(3,5-bis(triﬂuoromethyl)phenyl)-3-cyclohexyl-thiourea,
(−)-sparteine, CH2Cl2, room temp.); (iii) RAFT polymerization of TEGA (AIBN, CHCl3, 60 °C); (iv) self-assembly via direct dissolution in H2O; (v) nano-
particle loading with retinoic acid.
Table 1 Nanoparticle characterization
Dh,DLS (nm) PDDLS Zeta potential (mV) CMC
a (g L−1)
RM1 9.4 ± 1.5 0.30 −21.0 ± 0.7 —
RM2 51.0 ± 0.4 0.20 −27.2 ± 2.7 0.0036
a Critical micelle concentration (CMC) determined by fluorescence
spectroscopy.26
Fig. 1 Dry-state TEM images of (A) NIPAM nanogels RM1 and
(B) micelles, RM2, unstained on a graphene oxide substrate.
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Nanoparticles are well tolerated and eﬃciently internalized by
postnatal SVZ neural stem cells
Following birth, neurogenesis takes place mainly in restricted
neurogenic areas, such as the SVZ, from a highly specialized
cell population known as NSC, which can give rise to neurons,
astrocytes and oligodendrocytes, thus contributing the adult
brain homeostasis.3 These characteristics have triggered inter-
est in these cells as strong candidates for stem-cell based brain
repair strategies.4 Previous studies suggest that PEI- and PLGA-
based nanoparticles can be internalized into SVZ NSC and
deliver active pharmaceutical molecules aiming at controlling
the neuronal diﬀerentiation potential of these cells toward
inducing neurogenesis in the adult brain.4,15 Here, we develo-
ped an approach to directly image internalization of polymeric
nanoparticles by means of fluorescent tagged molecules, and
as a second step assess their potential as drug delivery
systems. The cellular uptake and internalization potential of
two diﬀerent types of fluorescent nanoparticles, organic
N-isopropylacrylamide (RM1) based nanogels and DTM-
labelled block copolymer micelles (RM2) was evaluated.
Adherent monolayers of NSC isolated from the postnatal SVZ
by means of MACS sorting for CD 133+ followed by enrichment
through neurosphere culture were used.32 Cells were exposed
to diﬀerent concentrations of RM1 and RM2 fluorescent nano-
particles for diﬀerent time periods, and their intracellular
internalization was studied by fluorescence microscopy.32
Fluorescently labelled RM1 and RM2 nanoparticles (from
40 to 150 μg ml−1 concentration) were applied to adherent NSC
cultures and their uptake monitored at regular intervals, from
4 up to 48 h (see Fig. S5† for data at 48 h). The nanoparticles
were well tolerated by the NSC, as assessed by morphological
evaluation, although mild flattening of the processes was
observed in the cultures treated with RM2 (Fig. 2a–f ) and they
could be identified within the cytoplasm of the cells
(additional images in Fig. S6†). In the case of PLGA nano-
particles, with an average particle size of 200 nm, the internal-
ization was observed 3 h post treatment while for the majority
of the other nanoparticles 24 hours were required to observe
internalization.15 The minimum time for the internalization of
nanoparticles in NSC is reported to be one hour for PEI based
nanoparticles with a size of 224 nm. Nanoparticles can still be
identified mainly in the cytoplasm of the NSC after
18–24 hours.4 We observed internalization of both RM1 and
RM2 nanoparticles (at a minimal concentration of 70 μg ml−1)
after 4 hours. The nanoparticles were identified in the cyto-
plasm of NSC with a punctate distribution, while the nucleus
was spared, an observation which is in line with previous
reports.19 The fluorescence of the nanoparticles was not quan-
tified in these experiments, as the confocal microscopy only
provides qualitative measurements. The purpose of these
studies carried out using fluorescent nanoparticles was to
confirm internalisation and therefore validate the data
obtained from the MTT proliferation assay.
Next, we set up to assess whether essential biological func-
tions of NSC were altered by the nanoparticles. Viability/
proliferation was assessed at two diﬀerent time points (4 and
24 hours) post treatment with diﬀerent concentrations of RM1
and RM2 (40, 70 and 150 μm ml−1) (Fig. 2g and h). Cell viabi-
lity/proliferation, as assessed by the MTT assay, was not signi-
ficantly aﬀected at 4 hours by any concentration of nano-
particles (mean viability ≥95% as compared to 100% viability
in the control sample where no nanoparticles were added,
Fig. 2g). Only a mild but significant reduction of viability was
noted for RM2 (≥90% as compared to untreated cells, Fig. 2h)
24 hours after treatment. In general, NIPAM based nano-
particles (RM1) were better tolerated in comparison with RM2,
regardless of the concentration. However, viability was high
(at above 90%) for both NPs.
The data obtained indicate that RM1 and RM2 nano-
particles are not toxic for NSC, as assessed by morphology and
viability, at a concentration equal or below 150 μg ml−1.
Nanoparticles do not impair multipotency and self-renewal of
murine neural stem cells
Next, the impact of the nanoparticles on the multipotency and
self-renewal of NSC was analysed. NSC are capable of trilineage
diﬀerentiating into neurons, astrocytes and oligodentro-
cytes.33,34 To assess the impact of the nanoparticles on the
multipotency of NSC, their ability to diﬀerentiate was tested.
Adherent monolayers of NSC were treated with either RM1 or
Fig. 2 Internalization of nanoparticles from SVZ NSC. Confocal
microscopy microphotographs of cells treated with RM1 and RM2 at 4 h
and 48 h and concentration of 70 and 150 μg ml−1 (a–f ). MTT
Proliferation Assay of the cells treated with diﬀerent concentration of
RM1 and RM2 nanoparticle, graphs g and h, (time of incubation with
nanoparticles was 4 hours). MTT assay was performed at t = 4 h and
t = 24 h.
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RM2 at a concentration of 70 μg ml−1 and induced to diﬀeren-
tiate by switching them into a neurobasal medium with B27
supplement but without growth factors, epidermal (EGF) and
basic fibroblast (FGF), which would otherwise prevent their
spontaneous diﬀerentiation. Quantification of the number of
astrocytes, neurons and oligodendrocytes arising from treated
and control cultures show no significant impact of the NPs
treatment on their diﬀerentiation capability (Fig. 3).
To assess the self-renewal capacity of NSC treated with the
nanoparticles, adherent monolayers, which had been treated
with 70 μg ml−1 of either RM1 or RM2, were allowed to grow to
confluency and then replated in neurosphere inducing con-
ditions.32 The formation of neurospheres was recorded and
the cultures dissociated and replated three times (Fig. 4).
Neurospheres were obtained in all cultures and no significant
impact on the eﬃciency of neurosphere formation was
observed (Fig. 4).
Taken together these experiments demonstrate that NCSs
treated with RM1 or RM2 at a concentration up to 70 μg ml−1
retain their cardinal features of multipotency and self-renewal
and raise the possibility that they could be used as a drug
delivery vehicle to NSC. Interestingly the data suggest that the
diﬀerences in chemical structure, with RM1 being a covalently
cross-linked system and RM2 a self-assembled micelle matrix,
do not significantly impact their potential as drug delivery
systems for NSC. This may suggest that size, which is in fact
comparable between the two systems, is playing a major role
in determining toxicity and cellular uptake.
Retinoic acid (RA) uploading on nanoparticles and
pharmacological eﬀect on NSC
Many pharmaceutical agents face the challenge of decreased
bioavailability as a result of poor aqueous solubility and short
half-life. Moreover the administration route or frequency can
often cause undesired side eﬀects. Encapsulation of the bio-
active factor in a polymer matrix can significantly increase
solubility and bioavailability and therefore enhance pharmaco-
logical activity. For the purpose of this study retinoic acid was
chosen as the model drug based on its two main character-
istics. It is a pharmaceutically active molecule that faces the
challenge of being practically insoluble in aqueous solutions
and it is also known to play an important role in controlling
neuronal diﬀerentiation of NSC.35 It is important to highlight
that given the extremely low solubility in aqueous phase, this
drug when tested in vitro needs to be partially solubilized by
the addition of small percentages of DMSO (0.6% in culture
media). Furthermore the drug alone cannot reach the blood
brain barrier and therefore requires an excipient to solubilize
and favor permeation.
For the uploading of retinoic acid on the thermoresponsive
nanoparticle, RM1, a modified version of a previously pub-
lished protocol was utilized.36 Retinoic acid was diluted in an
appropriate solvent containing the dispersed nanogels. In an
eﬀort to maximize the uploading, the experiment was con-
ducted at 4 °C. At this temperature the cross-linked network of
nanogel is swollen, allowing the dissolved molecules of the
drug to be incorporated with the possible creation of hydrogen
bonds. The RM1 nanoparticles and retinoic acid solution were
stirred for 72 hours to promote formation of a complex
Fig. 3 Assessment of multipotency of SVZ NSC before (control) and
after exposure to RM1 and RM2 nanoparticles (concentration: 70 μg ml−1).
Representative pictures showing the typical morphology of GFAP-
positive astrocytes (red) (a, d, g), MAP2-positive neurons (green) (b, e, h),
O4-positive oligodentrocytes (green) (c, f, i) and DAPI staining (blue
nuclei) in the untreated cells (control) (a–c) and in cells treated with
RM1 (d–f ) or RM2 (g–i) nanoparticles (concentration: 70 μg ml−1). The
percentage of neurons, astrocytes and oligodendrocytes after 5 days of
diﬀerentiation in control and cultures treated with RM1 and RM2 (con-
centration: 70 μg ml−1) is shown in the graph.
Fig. 4 Assessment of self-renewal. Neurospheres originating from SVZ
NSC treated with nanoparticles (RM1 and RM2, concentration: 70 μg ml−1)
or untreated (control) for 4 hours. The neurospheres were dissociated
and replated three times.
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between the carboxylic acid of retinoic acid and secondary
amine groups of the fluorescent tag available on the polymeric
cross-linked network. The nanogels were then isolated by
dialysis and freeze dried. The yield as well as drug loading and
entrapment eﬃciency for sample RM1 were determined by
UV-Vis spectroscopy (Table 2), using the calibration curve
(Fig. S7†).
Unlike the cross-linked nanogels, the spherical micelles
were not stable to organic solvent; therefore particles were
loaded via self-assembly in the presence of retinoic acid.
Polymer and retinoic acid were mixed in a solution of dichloro-
methane, before removal of the solvent. Addition of water
achieved self-assembly by direct dissolution, with dialysis to
remove non-encapsulated retinoic acid. A portion of the resul-
tant micelle solution was freeze-dried, allowing yield, drug
loading and entrapment eﬃciency to be determined by UV-Vis
spectroscopy.
Comparison of data obtained for the two sets of nano-
particles demonstrated that in the case of RM2 both drug
loading and entrapment eﬃciency were considerably lower
than for NIPAM-based nanogels (RM1). Attempts to increase
encapsulation eﬃciency for RM2 by using a 100× higher quan-
tity of retinoic acid were unsuccessful, with only 0.11% drug
loading obtained. It has been previously reported that poly-
meric micelles with an unmodified polyester core have low
entrapment eﬃciencies,37 leading to the decision of evaluating
the pharmacological activity using only RM1 nanogels.
The NIPAM based nanogels were also chosen because of
their thermoresponsive characteristics, which allows them to
undergo conformational changes as a function of temperature.
This property is dependent on the chemical structure of the
nanogel and the degree of crosslinking. The thermoresponsive
characteristics of RM1 were studied using UV-vis spectroscopy
and monitoring the change of transmittance as a function of
temperature in both water and medium. The data (Fig. S8†)
show that RM1 nanogels respond around 37 °C in water, and
around 38.5 °C in medium. This ensured that the drug would
be released when the loaded nanogels were incubated with the
cells.
In order to evaluate the pharmacological eﬀect to the NSC,
retinoic acid loaded nanogels (RM1 + Ret), at a concentration
of 70 μg ml−1, were incubated for 48 hours with neural stem
cells in medium not containing growth factors at 37 °C. After
this time the nanoparticles were removed, new fresh medium,
without growth factors, was added and the cells were allowed
to diﬀerentiate for 5 days. We already demonstrated that at
70 μg ml−1, nanogels do not aﬀect the main characteristics of
viability, multipotency and self-renewal of the NSC. Based on
the entrapment eﬃciency calculated for RM1, the maximum
concentration of the RA delivered to the SVZ NSC would be 4.6
nM. In order to evaluate the pharmacological eﬀect of the
cargo release, a solution of RA of similar concentration was
also added. However given the almost complete insolubility of
RA in water, 0.6% of DMSO had to be added. As previously
reported, most in vitro studies using cultures of NSC isolated
from the SVZ and hippocampus, suggest that RA exposure
stimulates neurogenesis and neuronal maturation.38
Fig. 5 shows the results which clearly indicate that there is
a significant increase in the percentage of neurons formed in
both samples, the one treated with the loaded nanogels (RM1
+ Ret) as well as the positive control (+Ret). Given that it was
previously demonstrated that RM1 nanogels had no impact on
diﬀerentiation, this result can only be attributed to the release
of retinoic acid. The observation that the RA-loaded RM1 par-
ticles provide very similar results to the positive control
demonstrates the potential eﬃciency of the delivery system.
Our results are in good correlation with previous reports where
Fig. 5 Impact of retinoic acid release from RM1 on SVZ NSC diﬀeren-
tiation. (A) Representative pictures showing a typical morphology of
MAP2-positive neurons (green) and DAPI staining (blue nuclei) in diﬀer-
entiated NSC cultures in the absence (negative control) or in the pres-
ence of RA (positive control) and RM1 loaded nanoparticles (70 μg ml−1,
4.6 nM in RA). (B) Percentage of neurons after 5 days of diﬀerentiation in
control cultures and in cultures exposed for 48 hours to a concentration
of 70 μg ml−1 RA. Retinoic acid (4 nM) solutions were prepared using
0.6% DMSO to solubilise the drug.
Table 2 Polymer chemical yield, drug loading (wt%) and entrapment
eﬃciency (wt%) of retinoic acid-loaded nanoparticles
Sample Yield, % Drug loading, % Entrapment eﬃciency, %
RM1 72 4.72 35.9
RM2 84 0.11 9.2
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the formation of neurons can be enhanced with con-
centrations of retinoic acid between 4 and 40 nM.4 Given the
drawbacks of retinoic acid as NSC drug e.g. its extremely low
water solubility, the formulation of this drug into nano-
particles may be an alternative approach for delivering such
hydrophobic drug in the brain. NIPAM based nanogels are
uptaken by the NSC, where they remain in the cytoplasm for at
least 24 hours as demonstrated by the data. This time length is
suﬃcient for the nanogels to react in terms of thermorespon-
siveness to the temperature of the environment. At 37 °C, the
nanogels shrink allowing the loaded retinoic acid to be
released by diﬀusion and give rise to the pharmacological
eﬀect of the enhanced formation of neurons.
Conclusion
In this study we demonstrate that NIPAM nanogels and
P(TEGA)-b-P(D,LLA)2 based micelles are taken up and interna-
lized in the cytoplasm of the SVZ neural stem cells, without
having any significant impact on their proliferation, diﬀeren-
tiation and self-renewal properties. The fluorescent labeling of
the nanoparticles via covalent bonds ensures that in vitro track-
ing, for the purpose of demonstrating internalization, is accu-
rate and removes uncertainty due to leaking. Interestingly the
variation in chemical structure between the two systems does
not appear to impact toxicity and cellular internalization,
suggesting that size, instead, is a key feature in this regard.
However the structural features do play a significant role in
determining the loading capacity and entrapment eﬃciency
and in fact RM2, the micelle system, shows a significantly
lower loading capacity, as a result of the compact packing of
the amorphous poly(D,L-lactide) core, and was therefore not
used further. The thermoresponsive nanogels RM1 can be
used in concentrations up to 150 μg ml−1, significantly higher
than previously reported17 and were synthesized to respond to
temperatures around 37 °C. When loaded with retinoic acid
the nanogels can be easily dissolved in aqueous solutions and
show a clear pharmacological eﬀect, with increase in neurons
production, as a result of modulation of SVZ neural stem cells.
The high concentration of nanogels that can be used, together
with the good loading eﬃciency and the thermoresponsive
properties, ensures higher bioavailability for small drug mole-
cules, such as retinoic acid that is practically insoluble in
water, as well as tailored delivery around 37 °C. These data are
promising for a future application of these nanoparticles for
drug delivery.
Materials and methods
Materials
All-trans retinoic acid, N-isopropylacrylamide, N,N′-methylene-
bisacrylamide, azobisisobutyronitrile (AIBN), were pur-
chased from Sigma-Aldrich. Dimethyl sulfoxide (DMSO) and
dichloromethane were acquired from Fisher. The dual func-
tional initiator,39 thiourea catalyst,40 and TEGA,41 were syn-
thesized as previously reported. D,L-Lactide was donated by
Purac and further purified/dried over 4 Å molecular sieves in
dichloromethane before being dried under vacuum and sub-
limed. (−)-Sparteine was dried over CaH2 and distilled prior to
use. All other reagents were used without further purification.
Synthesis of fluorescent nanogels (RM1)
Nanogels were prepared by high dilution radical polymeriz-
ation as previously described.28 N-Isopropylacrylamide,
N-2-(6-(4-methylpiperazin-1-yl)-1,3-dioxo-1H-benzo[de]isoquinolin-
2(3H)-yl-ethyl)acrylamide, N,N′-methylenebisacrylamide, in
molar ratios of 75 : 5 : 20 respectively, were dissolved in anhy-
drous DMSO with 1% AIBN and reacted at 70 °C for two days.
The clear solution was dialyzed against water for 2 days with
frequent changes. Nanogel solution was frozen and lyophilized
to give a white dry powder, which was stored at room
temperature.
Polymer synthesis and preparation of polymeric nanoparticles
(RM2)
The fluorescent poly(TEGA)-poly(D,L-lactide) amphiphilic block
copolymer was prepared as described previously.28
Poly(D,L-lactide)
To a solution of dual functional initiator (70.0 mg,
0.11 mmol), D,L-lactide (0.641 g, 4.4 mmol), and thiourea cata-
lyst (82.3 mg, 0.22 mmol) dissolved in dry DCM (6.41 mL) was
added (−)-sparteine (25.5 µL, 0.11 mmol). The reaction was
stirred at room temperature for 2 hours to a monomer conver-
sion of 100%, before precipitation into an excess of n-hexane.
The solid was filtered oﬀ and then redissolved in a good
solvent and re precipitated again into an excess of hexane. The
resultant polymer was purified via a prep SEC column, to yield
a yellow solid. Mn,NMR = 6.7 kg mol
−1, Mn,SEC = 9.8 kg mol
−1,
ĐSEC = 1.08. Size exclusion chromatography (SEC) measure-
ments were conducted using a Varian 390-LC-Multi detector
suite fitted with diﬀerential refractive index (DRI), and UV-Vis
or photodiode array (PDA) detectors. A guard column (Varian
Polymer Laboratories PLGel 5 µm, 50 × 7.5 mm) and two
mixed D columns (Varian Polymer Laboratories PLGel 5 µm,
300 × 7.5 mm, MW cut-oﬀ ∼400 000 g mol−1) were used with a
500 μl sample loop. The mobile phase was tetrahydrofuran
with 2% triethylamine at a flow rate of 5.0 ml min−1.
Amphiphilic block copolymer
A solution of poly(D,L-lactide) (25 mg, 3.71 µmol), TEGA
(80.0 µL, 0.408 mmol), and AIBN (0.152 mg, 0.926 μmol) in
CHCl3 (240 µL) was added to a polymerization ampoule. The
solution was degassed by three freeze–pump–thaw cycles and
sealed under N2. The reaction was stirred at 60 °C for 16 hours
to a monomer conversion of 95%, at which point the reaction
was quenched by rapid cooling with ice bath. The solvent was
removed in vacuo, and the residue was purified by dialysis
(MWCO 6–8000 Da) against distilled water. The product was
obtained as a fluorescent yellow waxy solid by lyophilisation
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from water (Mn,NMR = 28.4 kg mol
−1, Mn,SEC = 20.1 kg mol
−1,
ĐSEC = 1.22). Self-assembly was achieved by direct dissolution;
the amphiphilic block copolymer (10.4 mg) was dissolved in
water (18.2 MΩ cm) at 1 g L−1, and sonicated for 3 h to aﬀord
solutions of polymeric micelles.
Characterization of nanoparticles
The morphology of the nanoparticles was evaluated by trans-
mission electron microscopy (JEOL 2000FX). For both systems
a drop of nanoparticle solution (10 µL, 1 g L−1) was placed on
a graphene oxide support film on Lacey carbon on 400 mesh
Cu grid (Agar Scientific). After 1 minute the excess solution
was wicked away, and the TEM grid was placed in a desiccator
for 30 min before imaging.
Particle sizes and zeta potentials were determined using
light scattering via Malvern Zeta-Sizer, with solutions filtered
before analysis. Micelles (RM2) were analyzed directly after
self-assembly, while nanogels (RM1) were suspended in water
(0.1 mg ml−1) and sonicated for a short time (1 min). Size
Measurements were performed at 25 °C. All measurements
were performed in triplicates and the results were reported in
terms of mean diameter ± SD.
Preparation of retinoic acid loaded nanoparticles
Encapsulation of retinoic acid in the NIPAM nanogels (RM1)
was achieved as described below. Retinoic acid was diluted in
acetonitrile (ACN) under N2 atmosphere (stock solution
1 mg ml−1). 10 mg of freeze-dried nanogels were dispersed in
4 ml of ACN at room temperature. 1 ml of stock solution of
diluted retinoic acid was added (ACN) to the polymer solution
and incubated at 4 °C for 72 hours with stirring. The samples
were then centrifuged at 20 °C, 5000 rpm for 20 min. The
nanoparticles were washed trice with ACN to remove any
remaining drug. The combined organic phases, containing the
un-encapsulated drug, were analysed by UV-vis spectroscopy by
monitoring absorbance at 364 nm and using the extinction
coeﬃcient ε364 = 60 200 M
−1 cm−1 previously determined from
the calibration curve. The loading was therefore determined by
diﬀerence between the amount of drug added to the solution
and the drug that remained unloaded. The nanogels obtained
after centrifugation were stored under vacuum at 4 °C until
further experimental use. All samples were analyzed in tri-
plicate. Nanoparticle yield, drug loading and drug entrapment
eﬃciency were calculated based on previously described
equations.42
Encapsulation of retinoic acid, into the polymer micelles
(RM2) was achieved as described below. Retinoic acid was dis-
solved in dichloromethane to give a stock solution of
0.15 mM. Polymer (9.7 mg), retinoic acid stock solution
(0.65 ml) and dichloromethane (9.05 ml) were mixed to give a
final polymer concentration of 1 g L−1 and final retinoic acid
concentration of 15 µM. Dichloromethane was removed
in vacuo, before addition of water (18.2 MΩ cm) and sonication
to eﬀect micelle self-assembly via direct dissolution. Excess
retinoic acid was removed by dialysis against water (18.2
MΩ cm). To determine the yield, drug loading and entrapment
eﬃciency 1 ml of the micelle solution was freeze-dried and
redissolved in dichloromethane. A UV-vis spectrum was
recorded, and compared with individual spectra of the
polymer (Fig. S5†), and with a retinoic acid calibration curve.
From these spectra the drug loading could be calculated,
using the measured extinction coeﬃcients of retinoic acid
(ε364 = 60 200 M
−1 cm−1) and RM2 (ε305 = 18 400 M
−1 cm−1).
SVZ NSC cultures and experimental treatments
Mice were culled at postnatal day 7 following procedures
approved by the Home Oﬃce UK (Animals Scientific
Procedures Act 1986, PPL 70/7275). A narrow piece of tissue
containing the SVZ located in the lateral wall of the lateral ven-
tricles was isolated from the forebrain (approximately 1–2 mm
wide and 2–4 mm long). The tissue was sliced using a tissue
chopper and homogenized, followed by mechanical dis-
sociation into single cell suspension. Cells were diluted 1 : 1 in
trypan blue (Fluka) to assess cell viability and counted in a
Neubauer chamber. The cells were MACS-sorted for CD133
(prominin1) according to the manufacturer’s protocol
(Miltenyi Biotech) and the eluted CD133+ cells counted with a
Neubauer chamber and plated in pre-heated stem cell culture
media in ultra low attachment 6-well plates (Corning) with a
concentration of 10 000–20 000 cells per cm2 in 2 ml stem cell
culture medium per well. The culture media was composed of
DMEM-F12 (GIBCO) supplemented with basic fibroblast
growth factor, 20 ng ml−1 (bFGF) (Peprotech), epidermal
growth factor, 20 ng ml−1 (EGF) (Peprotech) and 1% B27
(Invitrogen). Adherent monolayers of NSC were cultured in
multi well plates or flasks, which had been coated with
Matrigel (BD Bioscience).
Internalization studies
To assess the cellular uptake of nanoparticles by NSCs,
diﬀerent concentrations (0.01–500 μg ml−1) of fluorescent
nanogels and polymeric nano-assemblies were incubated with
the cells. For the internalization studies, NSCs were seeded in
24-well plates at a density of 25 000 cells per well in 500 μl cell
culture medium. 24–48 hours after plating, diﬀerent amounts
of fluorescent nanogels or self-assembled polymeric nano-
particles were added to the wells. Cells were incubated with
nanoparticles up to 4 h at 37 °C 5% CO2, then the medium
was removed and fresh medium was added. Cells were incu-
bated for 0, 24 and 48 h, then washed with PBS and fixed with
4% paraformaldehyde (PFA) for 10 minutes at room tempera-
ture. After further washing, plates were mounted using
Vectashield mounting medium (VECTOR). Fluorescent images
were acquired using an inverted confocal microscope (Zeiss
510, Inverted Meta Confocal).
MTT assay
NSC cultures were seeded in 24-well plates at a density of
25 000 cells per well in 500 μl cell culture medium as afore-
mentioned. At least 24 hours after plating, diﬀerent amounts
of nanogels or self-assembled polymeric nanoparticles were
added to the wells. Cells were incubated with nano-matrices
Nanoscale Paper
This journal is © The Royal Society of Chemistry 2016 Nanoscale, 2016, 8, 17340–17349 | 17347
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
7 
Se
pt
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
on
 2
7/
02
/2
01
7 
14
:2
8:
00
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
for 4 hours at 37 °C 5% CO2. The MTT assay was performed at
4 hours and at 24 hours. Media was removed from the wells
and the cells washed with PBS. MTT solution (stock solution:
5 mg ml−1 in PBS pH 7.4) was added into each well in a ratio
1 : 10 (MTT stock solution: medium) and plates were incubated
at 37 °C for 24 h. The medium was removed, 300 μl iso-
propanol was added in each well and agitated thoroughly to
dissolve the formazan crystals. The solution was transferred to
96-well plates and immediately read by a microplate reader at
570 nm wavelength. The experiments were performed in
triplicates.
Multipotency assay
For multipotency assessment, NSCs were allowed to diﬀeren-
tiate for 5 days in vitro on matrigel coated glass cover slips.
Cells were seeded in 24-well plates at a density of 80 000 cells
per well in 500 μl cell culture medium and allowed to attach
for at least 24–48 hours. Almost confluent adherent mono-
layers of NSC were treated with loaded or un-loaded nano-
matrices dispersed in diﬀerentiating media, for at least
4 hours (minimum time period for internalization) and up to
48 hours. The medium was then removed, fresh media was
added and cells were allowed to diﬀerentiate for 5 days in vitro.
The diﬀerentiating media was composed of serum free neuro-
basal media (GIBCO) supplemented with 1% of B27. After five
days of incubation the cover slips were washed with PBS, fixed
with 4% PFA, rewashed with PBS and processed for immuno-
cytochemistry. At least three biological replicas were used for
the experiments.
Neurosphere assay
For the self-renewal assay, NSC were seeded in 24-well plates at
a density of 25 000 cells per well in 500 μl cell culture medium
as aforementioned. At least 24–48 hours after plating, fluo-
rescent nanogels or self-assembled polymeric nanoparticles
were added to the wells. Cells were incubated with nano-
matrices for 4 h at 37 °C 5% CO2. After four hours the excess
of nano-matrices was removed and fresh media was added.
Cells were incubated until almost confluent and passaged to
uncoated plates, allowed to form neurospheres. The neuro-
spheres were dissociated and replated three times.
Immunocytochemistry
To detect intracellular antigens, cells were treated with 0.1%
Triton X-100 solution in PBS for 10 min at RT. Primary anti-
bodies were diluted in 10% normal goat serum (NGS) in order
to avoid unspecific binding. Cells were incubated overnight at
4 °C in the primary antibody solution. The following day they
were washed with PBS, and incubated for 45 min in the dark
at RT with the corresponding secondary antibody also diluted
in 10% NGS. Antibodies were used as listed below. Primary
antibodies: rabbit polyclonal anti-GFAP (1 : 400) (DAKO);
mouse monoclonal anti-MAP2 (1 : 400) (Sigma); mouse mono-
clonal anti-O4 (1 : 400) (Millipore). Secondary antibodies: Alexa
Fluor 546 mouse anti-rabbit (1 : 1000); Alexa Fluor 488 anti-
mouse (1 : 1000) (Invitrogen). Slides were washed three times
in PBS for 5 minutes and mounted with DAPI mounting media
(VECTOR). Fluorescent images, five for each sample, magni-
fication 40×, were acquired using an epifluorescent Leica
microscope.
Statistical analysis
Data are expressed as means ± standard deviation or ±standard
error of mean (SEM). Statistical significance was determined
by one way Anova. In case of MTT assay a two way Anova was
performed. P < 0.05 was considered to represent statistical
significance.
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